Publications

  Schubert, S.Y., Lansky, E.P., Neeman, I., 1999. Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids. Journal of Ethnopharmacology 66, 11-7.

  Kim, N.D., Mehta, R., Yu, W., Neeman, I., Livney, T., Amichay, A., Poirier, D., Nicholls, P., Kirby, A., Jiang, W., Mansel, R., Ramachandran, C., Rabi, T., Kaplan, B., Lansky E., 2002.  Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer.  Breast Cancer Research and Treatment 71, 203-17.

Hora, J.J., Maydew, E.R., Lansky, E.P., Dwivedi, C., 2003.  Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice.  Journal of Medicinal Food  6, 157-61.

  Toi, M., Bando, H., Ramachandran, C., Melnick, S.J., Imai, A., Fife, R.S., Carr, R.E., Oikawa, T., Lansky, E.P., 2003.    Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo.   Angiogenesis 6, 121-8.

  van Elswijk, D.A., Schobel, U.P., Lansky, E.P., Irth, H., van derGreef, J., 2004.  Rapid dereplication of estrogenic compounds in pomegranate (Punica granatum) using on-line biochemical detection coupled to mass spectrometry.  Phytochemistry 65, 233-41.

Kawaii, S., Lansky, E.P 2004.  Differentiation-promoting activity of pomegranate (Punica granatum) fruit extracts in HL-60 human promyelocytic leukemia cells.  Journal of Medicinal Food 7,  13-8.

Mehta, R., Lansky, E.P., 2004.   Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture.  European Journal of Cancer Prevention 13,  345-8.

Albrecht, M., Jiang, W.,, Kumi-Diaka, J., Lansky, E.P., Gommersall, L.M., Patel, A., Mansel, R.E., Neeman, I., Geldof, A.A., Campbell, M.J. , 2004.  Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells.  Journal of Medicinal Food  7, 274-83.

  Lansky, E.P., Jiang, W., Mo, H., Bravo, L., Froom, P., Yu, W., Harris, N.M., Neeman, I., Campbell, M.J., 2005.  Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions.  Investigational New Drugs  23, 11-20.

Lansky, E.P., Harrison, G., Froom, P., Jiang, W.G., 2005.  Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel.  Investigational New Drugs  23, 121-2.  Erratum in: Investigational New Drugs 2005, 23, 379.

  Lansky, E.P., von Hoff, D.D., 2005. Complex and simple.  Leukemia Research 29, 601-2.

  Aslam, M.N., Lansky, E.P., Varani, J., 2006.  Pomegranate as a cosmeceutical source: pomegranate fractions promote proliferation and procollagen synthesis and inhibit matrix metalloproteinase-1 production in human skin cells.  Journal of Ethnopharmacology 103, 311-8.

  Lansky, E.P., 2006.  Beware of pomegranates bearing 40% ellagic acid.  Journal of Medicinal Food 9, 119-22.

  Lansky, E.P., Newman, R.A., 2007.  Punica granatum (pomegranate) and its potential for the prevention and treatment of cancer and inflammation.  Journal of Ethnopharmacology 109, 177-206.

  Katz, S.R., Newman, R.A., Lansky, E.P., 2007.  Punica granatum:  Heuristic treatment for diabetes mellitus.  Journal of Medicinal Food 10, 213-7.